News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2024-03-07 1:13:35 pm Unicycive Therapeutics Completes Enrollment in Pivotal Clinical Trial for Oxylanthanum Carbonate (OLC) GlobeNewsWire
2024-03-04 4:3:0 am Unicycive Therapeutics Announces Orphan Drug Designation Granted for UNI-494 by the U.S. Food and Drug Administration for the Prevention of Delayed Graft Function in Kidney Transplant Patients GlobeNewswire
2024-02-14 4:3:0 am Unicycive Therapeutics to Present Two Posters on Oxylanthanum Carbonate (OLC) at the Upcoming National Kidney Foundation Spring Clinical Meeting GlobeNewswire
2024-02-06 3:13:39 am We're Keeping An Eye On Unicycive Therapeutics' (NASDAQ:UNCY) Cash Burn Rate Simply Wall St.
2024-01-29 4:3:0 am Unicycive Therapeutics Announces Both an Oral and Poster Presentation to be Delivered on UNI-494 at the Upcoming AKI and CRRT Conference GlobeNewswire
2024-01-24 6:39:0 am Unicycive (UNCY) Up on Positive Hyperphosphatemia Study Update Zacks
2024-01-23 4:3:0 am Unicycive Therapeutics Issues Shareholder Letter to Highlight Corporate Progress and Key Upcoming Milestones GlobeNewswire
2023-12-18 4:3:0 am Unicycive Therapeutics Announces Enrollment of First Patient in Pivotal Clinical Trial for Oxylanthanum Carbonate (OLC) in Patients with Chronic Kidney Disease on Dialysis GlobeNewswire
   

Please consider a small donation if you think this website provides you with relevant information